CRT 2026

CRT VALVE AORTIC: TAVR & PMVR: STATE OF THE FIELDS

Moderator(s)

• 

  Maurice Buchbinder, MD, FSCAI

  Medical Director
  Foundation for Cardiovascular Medicine
  San Diego, California, United States

  Disclosure information not submitted.
• 

  Michael J. Reardon, MD

  Professor and Allison Family Distinguished Chair of Cardiovascular Research
  Houston Methodist DeBakey Heart & Vascular Center
  Houston, Texas, United States

  Disclosure(s): BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); WL Gore & Associates: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)